June 24, 2024 Case studies: Expert care helps children with complex pulmonary hypertension thrive The Pulmonary Hypertension Program within the Children’s Health Heart Center has expertise in using all available medications to put babies and young children with various types of pulmonary hypertension on a path to recovery.
June 24, 2024 Groundbreaking study analyzes causes of post-pulmonary embolism syndrome to enhance care Pulmonary embolism (PE) and other blood clots in hospitalized children are increasing, and so is the rate of complications. Children's Health is leading a study to understand why post-PE complications arise – and what to do about them.
June 24, 2024 Can addressing socioeconomic disparities improve outcomes for children with solid tumors? Socioeconomic factors that impact health include geography, family income, education, race and housing. Understanding these factors are necessary to address health disparities. A recent study analyzes how socioeconomic factors impact clinical outcomes for children with solid tumors.
June 19, 2024 New drug trial for familial chylomicronemia syndrome (FCS) Children’s Health Lipid Disorders Program is the only one in the country enrolling children with familial chylomicronemia syndrome into a clinical trial for orlistat. Our pediatric endocrinologist answers questions about the trial and how to enroll.
May 20, 2024 4 techniques: Identifying the most effective surgery for Chiari malformations Large retrospective studies by pediatric neurosurgeons at Children’s Health show that more invasive techniques for Chiari malformations type 1 are both safe and more effective for certain patients.
April 9, 2024 New treatment improves quality of life for children with DMD Elevidys is a new gene therapy treatment for Duchenne Muscular Dystrophy (DMD). Learn how Elevidys increases dystrophin production in young children with DMD and its potential to profoundly improve quality of life.